1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
American Bio Medica Corporation

American Bio Medica Corporation

ABMC
American Bio Medica CorporationUS flagOther OTC
0.00
USD
- -
- -
4,810.00Market Cap
American Bio Medica Corporation
ABMC
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
0.64
0.58
0.45
0.48
0.43
0.43
0.4
0.31
0.25
0.2
0.17
0.13
0.11
0.12
0.05
0.02
0.02
Revenue per Share
-0.05
-0.04
-0.04
-0.03
-0.02
-0.05
-0.04
-0.02
-0.01
-0.01
-0.02
-0.03
-0.02
-0.02
-0.01
-0.03
0.02
Basic EPS, GAAP
-0.06
-0.02
0.01
-0.01
0.01
0.01
- -
- -
0.01
0.01
- -
-0.01
- -
-0.01
-0.02
-0.02
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.65
-0.69
-0.73
-0.77
-0.78
-0.83
-0.85
-0.83
-0.77
-0.73
-0.7
-0.72
-0.68
-0.65
-0.55
-0.52
-0.48
Book Value per Share
0.23
0.2
0.16
0.12
0.11
0.06
0.06
0.04
0.03
0.03
0.02
-0.01
-0.03
-0.04
-0.02
-0.05
-0.01
Tangible Book Value per Share
22
22
22
22
22
22
22
23
26
27
29
30
33
36
43
48
48
Basic Weighted Avg Shares
14
13
10
10
9
9
9
7
6
6
5
4
4
4
2
1
1
Sales/Revenue/Turnover
-6.17
-4.95
-6.91
-5.12
-1.57
-9.94
-12.72
-2.98
-0.21
-4.58
-6.33
-19.68
-16.22
-14.97
-53.16
-136.04
-154.9
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-1
-1
-1
- -
-1
-1
- -
- -
- -
-1
-1
-1
-1
- -
-1
1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.23
Effective Tax Rate (%)
-7.14
-6.72
-9.25
-7.2
-3.72
-11.89
-8.86
-6.73
-5.27
-6.15
-11.09
-26.55
-18.63
-19.19
-20.87
-154.44
117.24
Profit Margin (%)
4
3
3
3
2
- -
- -
- -
1
1
- -
- -
- -
-1
-2
-3
- -
Working Capital
1
1
2
1
1
- -
- -
- -
1
1
1
1
1
1
- -
- -
- -
LT Debt
5
4
3
3
2
1
1
1
1
1
1
- -
-1
-1
-1
-2
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4.53
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
ST Debt
2
2
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
48
Market Capitalization
1
- -
1

Working Capital

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
4
1
Payables & Accruals
2
1
1
ST Debt
2
2
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.67%
99.92%
147.78%
Free Cash Flow
-85.74%
-263.63%
14.12%
Net Income, GAAP
19.71%
46.89%
204.54%
Sales/Revenue/Turnover
-17.85%
-23.74%
-58.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
1
1
1
2
2022
- -
- -
- -
- -
1
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.01
-0.01
0.02
- -
-0.01
2022
-0.01
-0.01
-0.01
- -
-0.03
2023
0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
AccuStem Sciences Limited (ACMSY)
PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
Stratec SE (0RAR.L)
DNA Chip Research Inc. (2397.T)
Sonic Healthcare Limited (SKHHY)
Monash IVF Group Limited (MVF.AX)
Business
American Bio Medica Corporation (ABMC) develops, manufactures, and markets lateral flow immunoassay tests primarily for the immediate, point-of-care detection of drugs of abuse in urine and oral fluids. The company offers core products including Rapid Drug Screen (RDS) and RDS InCup for urinalysis-based multi-drug screening; Rapid ONE and Rapid TOX series for single- and multi-panel urine tests; Rapid TOX Cup II, an integrated collection and testing cup; and OralStat for oral fluid-based drug detection; all certified under ISO 13485 standards with FDA-compliant manufacturing. ABMC serves workplace testing, criminal justice, rehabilitation, and healthcare markets across the United States and international regions. Founded in 1989 and headquartered in Kinderhook, New York, the company underwent a significant operational shift in 2023 when Healgen Scientific, LLC acquired its 22-acre headquarters and manufacturing facility in Columbia County, New York.

Company News

APIChatGPT

  • defenseworld.net

    American Bio Medica (OTCMKTS:ABMC) & Abbott Laboratories (NYSE:ABT) Head-To-Head Contrast

  • https://feeds.newsfilecorp.com

    HealthToday Unveils eBook on Diabetes Management Featuring Renowned Nutrition Experts

  • etftrends.com

    American Beacon Launches Natural Resources ETF

  • accesswire.com

    ABMC Reports Second Quarter 2021 Results